[Drug-induced hepatopathies].
D000328:Adult; D000367:Age Factors; D001663:Bilirubin / Q000097:blood; D002462:Cell Membrane / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002779:Cholestasis / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005234:Fatty Liver / Q000139:chemically induced; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008862:Microsomes, Liver / Q000201:enzymology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism; D011247:Pregnancy; D013752:Tetracycline / Q000009:adverse effects
D004364:Pharmaceutical Preparations; D013752:Tetracycline; D001663:Bilirubin; D006221:Halothane; D008727:Methotrexate
Hepatopatie polekowe.